This raises the possibility that targeting the complement system, for example, through the modulation of the C5a/C5aR1 and/or C3a/C3aR axes, may provide an effective novel approach to counteract fungal infection of the vaginal mucosa. This evidence concerns the gene C3 and fungal infectious disease.